• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CDY
Click for more information
1.43% 7.1¢

CELLMID LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
CDY Notice of Annual General Meeting/Proxy Form23/10/17
CDY CELLMID APPOINTS DR MARTIN CROSS AS NON-EXECUTIVE DIRECTOR16/10/17
CDY Date of Annual General Meeting12/10/17
CDY CELLMID RECEIVES $947K R&D TAX CREDITPRICE SENSITIVE03/10/17
CDY PROACTIVE INVESTORS EVENTS03/10/17
CDY INVESTORS PRESENTATION27/09/17
CDY CHANGE OF SHARE REGISTRY DETAILS25/09/17
CDY Change of Director's Interest Notices04/09/17
CDY Appendix 4G and Corporate Governance30/08/17
CDY Appendix 4E and Preliminary Final ReportPRICE SENSITIVE30/08/17
CDY CELLMID COMPLETES US CONSUMER STUDYPRICE SENSITIVE21/08/17
CDY CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLISPRICE SENSITIVE03/08/17
CDY Chinese Import Permits ReceivedPRICE SENSITIVE01/08/17
CDY Appendix 4C - quarterlyPRICE SENSITIVE28/07/17
CDY Nature Paper MK in MelanomaPRICE SENSITIVE03/07/17
CDY Change of Director's Interest Notice-Halasz05/06/17
CDY Appendix 3B15/05/17
CDY Change of Director's Interest Notice-Halasz15/05/17
CDY Change of Director's Interest Notice-Halasz12/05/17
CDY Company Secretary Appointment/Resignation27/04/17
CDY Appendix 4C - quarterlyPRICE SENSITIVE19/04/17
CDY Change of Director's Interest Notice - Halasz16/03/17
CDY Response to ASX query on Appendix 3Y13/03/17
CDY CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHEDPRICE SENSITIVE02/03/17
CDY Cellmid to Refinance R&D Loan FacilityPRICE SENSITIVE01/03/17
CDY Appendix 4D and Half Year AccountsPRICE SENSITIVE28/02/17
CDY MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCEPRICE SENSITIVE07/02/17
CDY CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWEDPRICE SENSITIVE31/01/17
CDY Appendix 4CPRICE SENSITIVE24/01/17
CDY CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMMEPRICE SENSITIVE18/01/17
CDY Change of Director's Interest Notice - Halasz18/01/17
CDY Cellmid Updates on CxBladder LicensePRICE SENSITIVE12/12/16
CDY Cellmid receives 831K R&D tax creditPRICE SENSITIVE29/11/16
CDY Results of Annual General Meeting21/11/16
CDY AGM Presentation by CEO21/11/16
CDY Change of Director's Interest Notice - Halasz17/11/16
CDY Cleansing Statement & Appendix 3B09/11/16
CDY USA launch of evolis-CDY.AX PRICE SENSITIVE03/11/16
CDY USA launch of evolisPRICE SENSITIVE03/11/16
CDY Cleansing Statement and Appendix 3B-CDY.AX 02/11/16
CDY Change of Director's Interest Notice - Halasz-CDY.AX 01/11/16
CDY ASX Market Release - Reinstatement-CDY.AX PRICE SENSITIVE01/11/16
CDY Cellmid Capital Raising-CDY.AX 01/11/16
CDY Appendix 4C - quarterly-CDY.AX 31/10/16
CDY Appendix 3B-CDY.AX 28/10/16
CDY Suspension from Official Quotation-CDY.AX PRICE SENSITIVE28/10/16
CDY Ceasing to be a substantial holder-CDY.AX 27/10/16
CDY Trading Halt-CDY.AX PRICE SENSITIVE26/10/16
CDY Exercise of Options (CDYO)-CDY.AX 25/10/16
CDY Appendix 3B-CDY.AX 21/10/16
CDY Notice of Annual General Meeting/Proxy Form-CDY.AX 19/10/16
CDY Change of Director's Interest Notice - King-CDY.AX 17/10/16
CDY Change of Director's Interest Notice - Halasz-CDY.AX 17/10/16
CDY Change of Director's Interest Notice - Walton-CDY.AX 17/10/16
CDY Change of Director's Interest Notice - Gordon-CDY.AX 17/10/16
CDY CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX PRICE SENSITIVE10/10/16
CDY Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer-CDY.AX PRICE SENSITIVE05/10/16
CDY Cellmid 2016 Annual Report to Shareholders-CDY.AX 29/09/16
CDY Quotation of Listed Options (CDYO)-CDY.AX 28/09/16
CDY Expiry Of Listed Options (CDYO)-CDY.AX 23/09/16
CDY European Midkine Patent For Surgical Adhesion Allowed-CDY.AX PRICE SENSITIVE22/09/16
CDY Change of Director's Interest Notice-CDY.AX 19/09/16
CDY Date of Annual General Meeting-CDY.AX 13/09/16
CDY Appendix 4G and Corporate Governance Statement-CDY.AX 31/08/16
CDY Appendix 4E and Preliminary Final Report-CDY.AX PRICE SENSITIVE30/08/16
CDY New Publication for Cellmid's Midkine Antibody-CDY.AX PRICE SENSITIVE09/08/16
CDY Cellmid Investor Presentation-CDY.AX 03/08/16
CDY Transcript of Cellmid Investor Briefing Call-CDY.AX PRICE SENSITIVE29/07/16
CDY Appendix 4C - quarterly-CDY.AX PRICE SENSITIVE26/07/16
CDY Ikon Legal Action,WPP-CDY.AX PRICE SENSITIVE22/07/16
CDY Cellmid Investor Briefing-CDY.AX 21/07/16
CDY USA Distribution Partnership for Cellmid's Evolis-CDY.AX PRICE SENSITIVE20/07/16
CDY Change in substantial holding-CDY.AX 18/07/16
CDY Change in substantial holding-CDY.AX 05/07/16
CDY Change in substantial holding-CDY.AX 04/07/16
CDY Change in substantial holding-CDY.AX 30/06/16
CDY Change in substantial holding-CDY.AX 29/06/16
CDY MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX 29/06/16
CDY Becoming a substantial holder-CDY.AX 28/06/16
CDY MK antibody publication and patent in bone healing-CDY.AX PRICE SENSITIVE24/06/16
CDY MK antibody publication and patent in bone healing-CDY.AX PRICE SENSITIVE24/06/16
CDY Change of Director's Interest Notice - Halasz-CDY.AX 20/06/16
CDY CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX 14/06/16
CDY Update on Japanese Sales-CDY.AX 26/05/16
CDY 4th MIDKINE SYMPOSIUM RESULTS-CDY.AX 11/05/16
CDY Significant Scientific Appointment for Advisory Board Chair-CDY.AX 09/05/16
CDY Appendix 4C - quarterly-CDY.AX PRICE SENSITIVE21/04/16
CDY Midkine Strategy Update-CDY.AX PRICE SENSITIVE08/04/16
CDY Fourth Midkine Symposium to be held in Budapest-CDY.AX 04/04/16
CDY Transcript of Cellmid Investor Briefing29/02/16
CDY Cellmid to Refinance RnD LoanPRICE SENSITIVE26/02/16
CDY Appendix 4D and Half Year AccountsPRICE SENSITIVE25/02/16
CDY Cellmid Investor Briefing23/02/16
CDY Director Appointment/Resignation04/02/16
CDY Appendix 4C - quarterlyPRICE SENSITIVE27/01/16
CDY Appendix 3Y - Maria Halasz18/12/15
CDY Cellmid receives $1.12M R&D Tax CreditPRICE SENSITIVE11/12/15
CDY Key Antibody Patent Granted in EuropePRICE SENSITIVE01/12/15
CDY Correction in Relation to Date of Announcement24/11/15
CDY Japanese Patent granted for use of Midkine for Hair GrowthPRICE SENSITIVE24/11/15
CDY Notice of Annual General Meeting/Proxy Form
23/10/17
CDY CELLMID APPOINTS DR MARTIN CROSS AS NON-EXECUTIVE DIRECTOR
16/10/17
CDY Date of Annual General Meeting
12/10/17
CDY CELLMID RECEIVES $947K R&D TAX CREDIT
03/10/17PRICE SENSITIVE
CDY PROACTIVE INVESTORS EVENTS
03/10/17
CDY INVESTORS PRESENTATION
27/09/17
CDY CHANGE OF SHARE REGISTRY DETAILS
25/09/17
CDY Change of Director's Interest Notices
04/09/17
CDY Appendix 4G and Corporate Governance
30/08/17
CDY Appendix 4E and Preliminary Final Report
30/08/17PRICE SENSITIVE
CDY CELLMID COMPLETES US CONSUMER STUDY
21/08/17PRICE SENSITIVE
CDY CELLMID SECURES PREMIUM US RETAIL CHANNEL FOR EVOLIS
03/08/17PRICE SENSITIVE
CDY Chinese Import Permits Received
01/08/17PRICE SENSITIVE
CDY Appendix 4C - quarterly
28/07/17PRICE SENSITIVE
CDY Nature Paper MK in Melanoma
03/07/17PRICE SENSITIVE
CDY Change of Director's Interest Notice-Halasz
05/06/17
CDY Appendix 3B
15/05/17
CDY Change of Director's Interest Notice-Halasz
15/05/17
CDY Change of Director's Interest Notice-Halasz
12/05/17
CDY Company Secretary Appointment/Resignation
27/04/17
CDY Appendix 4C - quarterly
19/04/17PRICE SENSITIVE
CDY Change of Director's Interest Notice - Halasz
16/03/17
CDY Response to ASX query on Appendix 3Y
13/03/17
CDY CELLMIDS FGF5 INHIBITOR CLINICAL STUDY PUBLISHED
02/03/17PRICE SENSITIVE
CDY Cellmid to Refinance R&D Loan Facility
01/03/17PRICE SENSITIVE
CDY Appendix 4D and Half Year Accounts
28/02/17PRICE SENSITIVE
CDY MIDKINE ALOPECIA PATENT EUROPEAN ALLOWANCE
07/02/17PRICE SENSITIVE
CDY CELLMID'S USA MIDKINE PATENT FOR ALOPECIA ALLOWED
31/01/17PRICE SENSITIVE
CDY Appendix 4C
24/01/17PRICE SENSITIVE
CDY CELLMID RECEIVES AUSTRALIAN GOVT GRANT FOR MIDKINE PROGRAMME
18/01/17PRICE SENSITIVE
CDY Change of Director's Interest Notice - Halasz
18/01/17
CDY Cellmid Updates on CxBladder License
12/12/16PRICE SENSITIVE
CDY Cellmid receives 831K R&D tax credit
29/11/16PRICE SENSITIVE
CDY Results of Annual General Meeting
21/11/16
CDY AGM Presentation by CEO
21/11/16
CDY Change of Director's Interest Notice - Halasz
17/11/16
CDY Cleansing Statement & Appendix 3B
09/11/16
CDY USA launch of evolis-CDY.AX
03/11/16PRICE SENSITIVE
CDY USA launch of evolis
03/11/16PRICE SENSITIVE
CDY Cleansing Statement and Appendix 3B-CDY.AX
02/11/16
CDY Change of Director's Interest Notice - Halasz-CDY.AX
01/11/16
CDY ASX Market Release - Reinstatement-CDY.AX
01/11/16PRICE SENSITIVE
CDY Cellmid Capital Raising-CDY.AX
01/11/16
CDY Appendix 4C - quarterly-CDY.AX
31/10/16
CDY Appendix 3B-CDY.AX
28/10/16
CDY Suspension from Official Quotation-CDY.AX
28/10/16PRICE SENSITIVE
CDY Ceasing to be a substantial holder-CDY.AX
27/10/16
CDY Trading Halt-CDY.AX
26/10/16PRICE SENSITIVE
CDY Exercise of Options (CDYO)-CDY.AX
25/10/16
CDY Appendix 3B-CDY.AX
21/10/16
CDY Notice of Annual General Meeting/Proxy Form-CDY.AX
19/10/16
CDY Change of Director's Interest Notice - King-CDY.AX
17/10/16
CDY Change of Director's Interest Notice - Halasz-CDY.AX
17/10/16
CDY Change of Director's Interest Notice - Walton-CDY.AX
17/10/16
CDY Change of Director's Interest Notice - Gordon-CDY.AX
17/10/16
CDY CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS-CDY.AX
10/10/16PRICE SENSITIVE
CDY Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer-CDY.AX
05/10/16PRICE SENSITIVE
CDY Cellmid 2016 Annual Report to Shareholders-CDY.AX
29/09/16
CDY Quotation of Listed Options (CDYO)-CDY.AX
28/09/16
CDY Expiry Of Listed Options (CDYO)-CDY.AX
23/09/16
CDY European Midkine Patent For Surgical Adhesion Allowed-CDY.AX
22/09/16PRICE SENSITIVE
CDY Change of Director's Interest Notice-CDY.AX
19/09/16
CDY Date of Annual General Meeting-CDY.AX
13/09/16
CDY Appendix 4G and Corporate Governance Statement-CDY.AX
31/08/16
CDY Appendix 4E and Preliminary Final Report-CDY.AX
30/08/16PRICE SENSITIVE
CDY New Publication for Cellmid's Midkine Antibody-CDY.AX
09/08/16PRICE SENSITIVE
CDY Cellmid Investor Presentation-CDY.AX
03/08/16
CDY Transcript of Cellmid Investor Briefing Call-CDY.AX
29/07/16PRICE SENSITIVE
CDY Appendix 4C - quarterly-CDY.AX
26/07/16PRICE SENSITIVE
CDY Ikon Legal Action,WPP-CDY.AX
22/07/16PRICE SENSITIVE
CDY Cellmid Investor Briefing-CDY.AX
21/07/16
CDY USA Distribution Partnership for Cellmid's Evolis-CDY.AX
20/07/16PRICE SENSITIVE
CDY Change in substantial holding-CDY.AX
18/07/16
CDY Change in substantial holding-CDY.AX
05/07/16
CDY Change in substantial holding-CDY.AX
04/07/16
CDY Change in substantial holding-CDY.AX
30/06/16
CDY Change in substantial holding-CDY.AX
29/06/16
CDY MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED-CDY.AX
29/06/16
CDY Becoming a substantial holder-CDY.AX
28/06/16
CDY MK antibody publication and patent in bone healing-CDY.AX
24/06/16PRICE SENSITIVE
CDY MK antibody publication and patent in bone healing-CDY.AX
24/06/16PRICE SENSITIVE
CDY Change of Director's Interest Notice - Halasz-CDY.AX
20/06/16
CDY CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS-CDY.AX
14/06/16
CDY Update on Japanese Sales-CDY.AX
26/05/16
CDY 4th MIDKINE SYMPOSIUM RESULTS-CDY.AX
11/05/16
CDY Significant Scientific Appointment for Advisory Board Chair-CDY.AX
09/05/16
CDY Appendix 4C - quarterly-CDY.AX
21/04/16PRICE SENSITIVE
CDY Midkine Strategy Update-CDY.AX
08/04/16PRICE SENSITIVE
CDY Fourth Midkine Symposium to be held in Budapest-CDY.AX
04/04/16
CDY Transcript of Cellmid Investor Briefing
29/02/16
CDY Cellmid to Refinance RnD Loan
26/02/16PRICE SENSITIVE
CDY Appendix 4D and Half Year Accounts
25/02/16PRICE SENSITIVE
CDY Cellmid Investor Briefing
23/02/16
CDY Director Appointment/Resignation
04/02/16
CDY Appendix 4C - quarterly
27/01/16PRICE SENSITIVE
CDY Appendix 3Y - Maria Halasz
18/12/15
CDY Cellmid receives $1.12M R&D Tax Credit
11/12/15PRICE SENSITIVE
CDY Key Antibody Patent Granted in Europe
01/12/15PRICE SENSITIVE
CDY Correction in Relation to Date of Announcement
24/11/15
CDY Japanese Patent granted for use of Midkine for Hair Growth
24/11/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
'Taking money from the market': Garbage giant cleans up as this week's Hot Stock tip Wealth Within chief analyst Dale Gillham and senior analyst Fil Tortevski have tipped $4.68 billion garbage giant Cleanaway Waste Management Limited (ASX:CWY) as their Hotcopper Hot Stock tip of the week @ especially because it seems to be slowly building towards a euphoric run akin to its mid 20...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.